A novel cryopreservation and biobanking strategy to study lymphoid tissue stromal cells in human disease
Joshua D. Brandstadter,Angelina De Martin,Mechthild Lϋtge,Antonio Ferreira,Brian T. Gaudette,Yves Stanossek,Shumei Wang,Michael V. Gonzalez,Edward Camiolo,Gerald Wertheim,Bridget Austin,David Allman,Adam Bagg,Megan S. Lim,David C. Fajgenbaum,Jon C. Aster,Burkhard Ludewig,Ivan Maillard
DOI: https://doi.org/10.1002/eji.202250362
2023-06-28
European Journal of Immunology
Abstract:Lymph node stromal cells play significant roles in host defense, autoimmunity, alloimmunity, and lymphoproliferative disorders. However, research in human disease has been limited due to a perceived need for fresh tissue. Here, we show how whole‐tissue cryopreservation can enable large‐scale biobanking to facilitate the study of lymph node stromal cells in human disease. Nonhematopoietic lymph node stromal cells (LNSCs) regulate lymphocyte trafficking, survival, and function for key roles in host defense, autoimmunity, alloimmunity, and lymphoproliferative disorders. However, the study of LNSCs in human diseases is complicated by a dependence on viable lymphoid tissues, which are most often excised prior to establishment of a specific diagnosis. Here, we demonstrate that cryopreservation can be used to bank lymphoid tissue for the study of LNSCs in human disease. Using human tonsils and lymph nodes (LN), lymphoid tissue fragments were cryopreserved for subsequent enzymatic digestion and recovery of viable nonhematopoietic cells. Flow cytometry and single‐cell transcriptomics identified comparable proportions of LN stromal cell types in fresh and cryopreserved tissue. Moreover, cryopreservation had little effect on transcriptional profiles, which showed significant overlap between tonsils and LN. The presence and spatial distribution of transcriptionally defined cell types were confirmed by in situ analyses. Our broadly applicable approach promises to greatly enable research into the roles of LNSCs in human disease.
immunology